Skip to content
healthcare.dev
Get a free key

Naproxen Sodium and Pseudoephedrine Hydrochloride Sinus and Headache

NDC 58602-832, Naproxen Sodium and Pseudoephedrine Hydrochloride, tablet, extended release, from Aurohealth LLC.

Product NDC
58602-832
Status
Listed
Labeler
Aurohealth LLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA211360
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58602-832 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAPROXEN SODIUM220 mg/1
  • PSEUDOEPHEDRINE HYDROCHLORIDE120 mg/1

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]; alpha-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
58602-832-67586020832672 BLISTER PACK in 1 CARTON (58602-832-67) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
58602-832-83586020832831 BLISTER PACK in 1 CARTON (58602-832-83) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 58602-832 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58602-832 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58602-832. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.